(Q80210009)
Statements
A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen (English)
Jean-Michel Molina
Margaret A Johnson
Joseph C Gathe
Daniel Podzamczer
Christian T Naylor
Yi-Lin Chiu
Martin S King
Thomas J Podsadecki
George J Hanna